IntelliCuff: l'approccio intelligente per gestire la pressione di cuffia

Illustrazione: pressione di cuffia controllata

Per una pressione di cuffia sempre sotto controllo e una maggiore sicurezza per il paziente

Una pressione di cuffia costantemente controllata e ottimizzata agevola la terapia di ventilazione e protegge i pazienti da lesioni tracheali e polmonite associata al ventilatore VAP (Lorente L, Lecuona M, Jiménez A, et al. Continuous endotracheal tube cuff pressure control system protects against ventilator-associated pneumonia. Crit Care. 2014;18(2):R77. Pubblicato il 21 aprile 2014. doi:10.1186/cc138371).

IntelliCuff fa la maggior parte di questo lavoro al posto dei medici. È sufficiente impostare la pressione di cuffia desiderata e IntelliCuff la mantiene automaticamente. Il dispositivo è in grado di funzionare in un intervallo di pressioni ampio ma sicuro e con diversi tubi endotracheali cuffiati.

Che lo si utilizzi per il trasporto aereo, con rapide variazioni di pressione ambientale, oppure in sala operatoria durante interventi chirurgici o sedazione con N2O, IntelliCuff monitora costantemente e mantiene la pressione di cuffia ottimale per garantire ai pazienti una maggiore sicurezza. Persino in alcune delle situazioni più critiche (Nseir S, Zerimech F, Fournier C, et al. Continuous control of tracheal cuff pressure and microaspiration of gastric contents in critically ill patients. Am J Respir Crit Care Med. 2011;184(9):1041-1047. doi:10.1164/rccm.201104-0630OC2).

Un compagno sempre accanto: compatto e portatile per ogni situazione

Adatto a pazienti adulti, pediatrici e neonatali. IntelliCuff garantisce una gestione sicura delle vie aeree in molte situazioni diverse: in terapia intensiva, in sala operatoria o durante il trasporto. È possibile utilizzarlo per interventi di soccorso a terra o in volo, anche ad altitudini elevate.

Basta un clic: un'ampia gamma di soluzioni di montaggio

Le diverse interfacce disponibili permettono di collocare IntelliCuff ovunque serva. Con un clic.

Ama giocare con tutti: compatibilità con i ventilatori

Il controller autonomo IntelliCuff è il compagno perfetto per i ventilatori Hamilton Medical.

Tutti i nostri ventilatori

Collage con gli ambiti d'uso di IntelliCuff

Buono a sapersi! Imparare a usare IntelliCuff

Accessori e prodotti di consumo

Tubo pressione di cuffia

Adattatore USB per auto

Gancio

Soluzione multipla di montaggio

Catalogo online

Per ulteriori informazioni

Documento

Note

Continuous endotracheal tube cuff pressure control system protects against ventilator-associated pneumonia.

Lorente L, Lecuona M, Jiménez A, et al. Continuous endotracheal tube cuff pressure control system protects against ventilator-associated pneumonia. Crit Care. 2014;18(2):R77. Published 2014 Apr 21. doi:10.1186/cc13837

Link to article

INTRODUCTION

The use of a system for continuous control of endotracheal tube cuff pressure reduced the incidence of ventilator-associated pneumonia (VAP) in one randomized controlled trial (RCT) with 112 patients but not in another RCT with 142 patients. In several guidelines on the prevention of VAP, the use of a system for continuous or intermittent control of endotracheal cuff pressure is not reviewed. The objective of this study was to compare the incidence of VAP in a large sample of patients (n = 284) treated with either continuous or intermittent control of endotracheal tube cuff pressure.

METHODS

We performed a prospective observational study of patients undergoing mechanical ventilation during more than 48 hours in an intensive care unit (ICU) using either continuous or intermittent endotracheal tube cuff pressure control. Multivariate logistic regression analysis (MLRA) and Cox proportional hazard regression analysis were used to predict VAP. The magnitude of the effect was expressed as odds ratio (OR) or hazard ratio (HR), respectively, and 95% confidence interval (CI).

RESULTS

We found a lower incidence of VAP with the continuous (n = 150) than with the intermittent (n = 134) pressure control system (22.0% versus 11.2%; p = 0.02). MLRA showed that the continuous pressure control system (OR = 0.45; 95% CI = 0.22-0.89; p = 0.02) and the use of an endotracheal tube incorporating a lumen for subglottic secretion drainage (SSD) (OR = 0.39; 95% CI = 0.19-0.84; p = 0.02) were protective factors against VAP. Cox regression analysis showed that the continuous pressure control system (HR = 0.45; 95% CI = 0.24-0.84; p = 0.01) and the use of an endotracheal tube incorporating a lumen for SSD (HR = 0.29; 95% CI = 0.15-0.56; p < 0.001) were protective factors against VAP. However, the interaction between type of endotracheal cuff pressure control system (continuous or intermittent) and endotracheal tube (with or without SSD) was not statistically significant in MLRA (OR = 0.41; 95% CI = 0.07-2.37; p = 0.32) or in Cox analysis (HR = 0.35; 95% CI = 0.06-1.84; p = 0.21).

CONCLUSIONS

The use of a continuous endotracheal cuff pressure control system and/or an endotracheal tube with a lumen for SSD could help to prevent VAP in patients requiring more than 48 hours of mechanical ventilation.

Continuous control of tracheal cuff pressure and microaspiration of gastric contents in critically ill patients.

Nseir S, Zerimech F, Fournier C, et al. Continuous control of tracheal cuff pressure and microaspiration of gastric contents in critically ill patients. Am J Respir Crit Care Med. 2011;184(9):1041-1047. doi:10.1164/rccm.201104-0630OC

Link to article

RATIONALE

Underinflation of the tracheal cuff frequently occurs in critically ill patients and represents a risk factor for microaspiration of contaminated oropharyngeal secretions and gastric contents that plays a major role in the pathogenesis of ventilator-associated pneumonia (VAP).

OBJECTIVES

To determine the impact of continuous control of tracheal cuff pressure (P(cuff)) on microaspiration of gastric contents.

METHODS

Prospective randomized controlled trial performed in a single medical intensive care unit. A total of 122 patients expected to receive mechanical ventilation for at least 48 hours through a tracheal tube were randomized to receive continuous control of P(cuff) using a pneumatic device (intervention group, n = 61) or routine care of P(cuff) (control group, n = 61).

MEASUREMENTS AND MAIN RESULTS

The primary outcome was microaspiration of gastric contents as defined by the presence of pepsin at a significant level in tracheal secretions collected during the 48 hours after randomization. Secondary outcomes included incidence of VAP, tracheobronchial bacterial concentration, and tracheal ischemic lesions. The pneumatic device was efficient in controlling P(cuff). Pepsin was measured in 1,205 tracheal aspirates. Percentage of patients with abundant microaspiration (18 vs. 46%; P = 0.002; OR [95% confidence interval], 0.25 [0.11-0.59]), bacterial concentration in tracheal aspirates (mean ± SD 1.6 ± 2.4 vs. 3.1 ± 3.7 log(10) cfu/ml, P = 0.014), and VAP rate (9.8 vs. 26.2%; P = 0.032; 0.30 [0.11-0.84]) were significantly lower in the intervention group compared with the control group. However, no significant difference was found in tracheal ischemia score between the two groups.

CONCLUSIONS

Continuous control of P(cuff) is associated with significantly decreased microaspiration of gastric contents in critically ill patients.

State accedendo al sito dal Paese Stati Uniti.
Per il vostro Paese (Stati Uniti) è disponibile anche una versione dedicata del sito.

O una curiosità? Contattateci